-
Product Insights
Likelihood of Approval Analysis for Acute Heart Failure
Overview How likely is it that the drugs in Acute Heart Failure will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Heart Failure Overview Acute heart failure (AHF) is a critical...
-
Track & Monitor
Robotics in medical: Guided robotic catheters
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the medical industry’s Guided robotic catheters within Robotics innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge...
-
Track & Monitor
Robotics in medical: guided robotic surgical tools
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the medical industry’s guided robotic surgical tools segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – STA-363 in Chronic Low Back Pain (CLBP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - STA-363 in Chronic Low Back Pain (CLBP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. STA-363 in Chronic Low Back Pain (CLBP) Drug Details:...
-
Track & Monitor
Virtual and augmented reality in medical: AR-guided medical intervention
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the medical industry’s AR-guided medical intervention segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Track & Monitor
Virtual and augmented reality in medical: AR-guided surgical navigation
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the medical industry’s AR-guided surgical navigation segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – InCVAX in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - InCVAX in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. InCVAX in Colorectal Cancer Drug Details: inCVAX is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – InCVAX in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - InCVAX in Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. InCVAX in Melanoma Drug Details: inCVAX is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – InCVAX in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - InCVAX in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. InCVAX in Solid Tumor Drug Details: inCVAX is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – InCVAX in Soft Tissue Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - InCVAX in Soft Tissue Sarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. InCVAX in Soft Tissue Sarcoma Drug Details: inCVAX is under...